Great team effort! Our new paper is out. 🎉 I am happy to share that our paper on multi-modal network analysis for lung cancer targets has been published in Communications Chemistry and selected for their special Nature Portfolio Collections on Computational methodology for drug discovery.
Namshik Han
@namshik.bsky.social
Cambridge scientist and entrepreneur exploring AI, Quantum, and Drug Discovery. Bridging computation and biomedicine for innovation.
In this interview from @elrig.org’s #DD25, @namshik.bsky.social explains quantum algorithms with a London Tube analogy, how they can be applied to benefit drug discovery and his advice for researchers wanting to launch their own startups >>> www.biotechniques.com/computationa...
Quantum questions have algorithmic answers: navigating a drug discovery network
In this interview, Namshik Han explains the role quantum algorithms can play in drug discovery research and what makes a successful startup.
biotechniques.com
🚀 From #Apollo to #Quantum! #IBM Watson Research powered the Apollo Missions, shaped supercomputing, and now leads Quantum Computing. Seeing System Two and discussing Quantum #DrugDiscovery collaborative projects with George Tulevski, Gopal Karemore, and Petra Florizoone was a privilege.
A #dozen years at the University of Cambridge! 🎉 From standing solo with a secret agent to now leading a #lab full of real-world scientific agents. What a ride! Honoured to have spent over a decade growing my #career in such an inspiring place. #Cambridge has been an incredible journey, onward!
Utilising multi-modal data-driven network analysis to identify monotherapy and combinational therapy targets in SOX2-dependent squamous cell lung cancer https://www.biorxiv.org/content/10.1101/2025.01.30.635634v1
Utilising multi-modal data-driven network analysis to identify monotherapy and combinational therapy targets in SOX2-dependent squamous cell lung cancer https://www.biorxiv.org/content/10.1101/2025.01.30.635634v1
🚀 Big news! Our first use of #quantum algorithms in #AI network-based #DrugDiscovery is a success! We applied #QuantumWalk-based analysis to explore #LongCOVID, identifying novel targets and pathways. A new era for our lab begins! doi.org/10.48550/arX... #QuantumAI #Biotech
🚀 New Preprint Alert! Our research shows how #AI #MultiModal #NetworkAnalysis identifies #Monotherapy & #CombinationalTherapy targets for SOX2-driven lung cancer. A scalable & validated approach for broader disease applications! 🔗 doi.org/10.1101/2025... #DrugDiscovery #MultiOmics